other_material
confidence high
sentiment neutral
materiality 0.50
Sensei Biotherapeutics delays Karen Vousden board appointment to later 2026; board size set to five
Sensei Biotherapeutics, Inc.
- Karen Vousden delays board appointment to later 2026 due to personal reasons; Board to consider appointment in Q3 or Q4 2026.
- If stockholder matters pass at June 10 annual meeting, Bob Holmen to become chair of Nominating and Corporate Governance Committee on June 12.
- Board size approved at five directors effective upon reconstitution.
- Annual meeting scheduled June 10, 2026; definitive proxy filed April 27.